American Diabetes Association

Skip to Main Content

Table 3—

Mean survival period and 5-year mortality

	Cases (n)	Deaths (n)	Survival (months)	5-year mortality (%)
Overall	185	52	50 (47–54)	44
Ulcer type
Neuropathic (N)	83	21	52 (48–57)	45
Neuroischemic (NI)	30	6	53 (45–61)^*	20
Ischemic (I)	44	20	41 (34–49)^†^‡	56^†^‡
Other	28	5	46 (42–51)	23^§
Amputation	30	9	50 (42–58)	47
No amputation	153	43	50 (46–54)	43

	Cases (n)	Deaths (n)	Survival (months)	5-year mortality (%)
Overall	185	52	50 (47–54)	44
Ulcer type
Neuropathic (N)	83	21	52 (48–57)	45
Neuroischemic (NI)	30	6	53 (45–61)^*	20
Ischemic (I)	44	20	41 (34–49)^†^‡	56^†^‡
Other	28	5	46 (42–51)	23^§
Amputation	30	9	50 (42–58)	47
No amputation	153	43	50 (46–54)	43

Data are means (95% CI) unless noted otherwise.

*

P = 0.05 for I vs. NI;

†

P < 0.05 for I vs. N;

‡

P < 0.05;

§

three-year mortality.